| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |